Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Mediterranean-Ketogenic Dietary Interventions in Parkinson's Disease: Protecting the Gut Microbiome
FY 2022-23
Summary
Parkinson's Disease (PD) is the second most common neurodegenerative disease worldwide and remains without a cure, or neuroprotective therapy capable of slowing disease progression. Recent studies in PD animal models have suggested a neuroprotective effect of low-carbohydrate, high-fat ketogenic diets (KDs). Pilot clinical trials have further demonstrated short-term symptomatic improvement in PD participants adhering to KDs. However, little is known about the safety of KDs in this clinical context. In the setting of PD, the effect of any dietary intervention on gut microbiome health is an area of particular concern, as disruptions in gut microbial composition are believed to play a prominent role in disease pathogenesis. Given that KDs have previously been linked to gut microbiome disturbances in populations without PD, modifications of this diet may be necessary before KDs can be safely implemented in individuals with PD. In contrast to KDs, the primarily plant-based Mediterranean diets are associated with improved gut microbiome health in patients with PD. To leverage the potential neuroprotective effects of KDs while minimizing risk to the gut microbiome, we have designed two combined Mediterranean-ketogenic dietary interventions to be tested in this pilot clinical trial in participants with PD. The primary goal of this study is to investigate the safety of these two Mediterranean-ketogenic interventions in patients with PD, as it relates to gut microbiome health. We hypothesize that these interventions will not be associated with significant gut microbiome perturbations in our participants. Results from our study will inform the design of larger trials investigating the long-term efficacy of Mediterranean-ketogenic interventions in patients with PD.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486246
Name
Tosefsky Kira N
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Mediterranean-Ketogenic Dietary Interventions in Parkinson's Disease: Protecting the Gut Microbiome
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Central Nervous System Diseases; Gut Microbiome; Ketogenic Diet; Lifestyle Interventions; Mediterranean Diet; Medium-Chain Triglycerides; Movement Disorders; Neurodegenerative Diseases; Parkinson'S Disease; Synucleinopathies
Abstract
Parkinson's Disease (PD) is the second most common neurodegenerative disease worldwide and remains without a cure, or neuroprotective therapy capable of slowing disease progression. Recent studies in PD animal models have suggested a neuroprotective effect of low-carbohydrate, high-fat ketogenic diets (KDs). Pilot clinical trials have further demonstrated short-term symptomatic improvement in PD participants adhering to KDs. However, little is known about the safety of KDs in this clinical context. In the setting of PD, the effect of any dietary intervention on gut microbiome health is an area of particular concern, as disruptions in gut microbial composition are believed to play a prominent role in disease pathogenesis. Given that KDs have previously been linked to gut microbiome disturbances in populations without PD, modifications of this diet may be necessary before KDs can be safely implemented in individuals with PD. In contrast to KDs, the primarily plant-based Mediterranean diets are associated with improved gut microbiome health in patients with PD. To leverage the potential neuroprotective effects of KDs while minimizing risk to the gut microbiome, we have designed two combined Mediterranean-ketogenic dietary interventions to be tested in this pilot clinical trial in participants with PD. The primary goal of this study is to investigate the safety of these two Mediterranean-ketogenic interventions in patients with PD, as it relates to gut microbiome health. We hypothesize that these interventions will not be associated with significant gut microbiome perturbations in our participants. Results from our study will inform the design of larger trials investigating the long-term efficacy of Mediterranean-ketogenic interventions in patients with PD.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tosefsky, Kira N
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~